Treatment

Home Research Research Grants Program Grants Awarded Grants Awarded By Research Topic Treatment

Grants classified within this field of interest focus on treatment of pancreatic cancer. According to the Common Scientific Outline, these projects deal with one or more of the following research topics: (1) localized therapies – discovery and development; (2) localized therapies – clinical applications; (3) systemic therapies – discovery and development; (4) systemic therapies – clinical applications; (5) combinations of localized and systemic therapies; (6) complementary and alternative treatment approaches; and (7) resources and infrastructure related to treatment. Click below to learn about these grants.

2013 Samuel Stroum – Pancreatic Cancer Action Network – AACR Fellowship
Andrew Aguirre, MD, PhD
Dana-Farber Cancer Institute
Validation of Novel KRAS Synthetic Lethal Targets in Pancreatic Cancer

2008 Randy Pausch, PhD – Pancreatic Cancer Action Network – AACR Pilot Grant
Nabeel Bardeesy, PhD
Massachusetts General Hospital
Molecular Markers of Drug Sensitivity in Pancreatic Cancer

grantee-Abel-98x982017 Pancreatic Cancer Action Network Precision Medicine Targeted Grant
Gregory Beatty, MD, PhD
University of Pennsylvania
Multiplex Tissue-based Assays and Analytical Tools for Pancreatic Cancer

2010 Samuel Stroum – Pancreatic Cancer Action Network – AACR Fellowship Award
Vikram Bhattacharjee, PhD
Fox Chase Cancer Center
Candidate Gene Validation of Sensitizers of Pancreatic Cancer to Gemcitabine

grantee-Abel-98x982017 Gail V. Coleman-Kenneth M. Bruntel – Pancreatic Cancer Action Network Translational Research Grant
Vladimir Bogdanov, PhD
Co-PI: Syed Arif Ahmad, MD
University of Cincinnati
Disrupting Tissue Factor-beta1 Integrin Axis in Pancreatic Cancer

2014 Pancreatic Cancer Action Network – Rising Tide Foundation – Gateway Clinical Continuation Research Grant
David Boothman, PhD
University of Texas Southwestern Medical Center
Exploiting an NQO1 ‘kiss of death’ for pancreatic cancer therapy

2015 Pancreatic Cancer Action Network Translational Research Grant
David Boothman, PhD, UT Southwestern Medical Center
Co-PI: Muhammad Beg, MD
Use of PARP1 inhibitors to leverage a tumor-selective ‘kiss of death’

2013 Abby Sobrato – Pancreatic Cancer Action Network – AACR Innovative Grant
Yves Boucher, PhD
Harvard Medical School
Targeting Desmoplasia in Pancreatic Cancer to Improve Drug Efficacy

2015 Pancreatic Cancer Action Network – AACR Research Acceleration Network Grant
Jonathan Brody, PhD, Thomas Jefferson University
Co-PI: Michael Pishvaian, MD, PhD, Georgetown University
Co-PI: Christopher Albanese, PhD, Georgetown University
Co-PI: Subha Madhavan, PhD, Georgetown University
Co-PI: Emanuel Petricoin III, PhD, George Mason University
Developing an algorithm for Molecular Tailored Therapy

Seena Magowitz – Pancreatic Cancer Action Network -- AACR Pilot Grant
George A. Calin, MD, PhD
MD Anderson Cancer Center
Roles of MicroRNAs and Ultraconserved Genes in Pancreatic Cancers

2012 The Daniel and Janet Mordecai Foundation – Pancreatic Cancer Action Network – AACR Career Development Award
Darren Carpizo, MD, PhD
University of Medicine & Dentistry of New Jersey – Robert Wood Johnson Medical School
Pre-clinical Studies of an Allele-Specific p53 Mutant Reactivating Compound in Pancreatic Cancer

2006 Pancreatic Cancer Action Network – ASCO Career Development Award
David Chang, MD, PhD
MD Anderson Cancer Center
Treating Pancreatic Cancer with the Well-characterized Anti-allergy Drug Cromolyn, Through a Novel Mechanism of Action

2016 Pancreatic Cancer Action Network – AACR Career Development Award (Grant funded by an anonymous foundation)
Shuibing Chen, PhD
Weill Cornell Medical College
Targeting Chemoresistant Stem Cells in Pancreatic Cancer

2008 Constance Williams – Pancreatic Cancer Action Network – AACR Career Development Award
Marie-Christine Daniel, PhD
University of Maryland, Baltimore County
Multifunctional Nanovectors for Pancreatic Cancer Therapy

2015 Pancreatic Cancer Action Network – AACR Research Acceleration Network Grant
Channing Der, PhD, University of North Carolina
Co-PI: Jason Fleming, MD, MD Anderson Cancer Center
Co-PI: Krister Wennerberg, PhD, University of Helsinki, Finland
Defining novel combination KRAS-targeted therapeutic strategies

grantee-Abel-98x982017 Pancreatic Cancer Action Network Translational Research Grant
Giulio Draetta, MD, PhD
MD Anderson Cancer Center
Therapeutic Vulnerabilities of Mesenchymal Pancreatic Cancer Cells

2012 Bonnie L. Tobin – Pancreatic Cancer Action Network – AACR Innovative Grant
Peter Espenshade, PhD
Johns Hopkins University
SREBP Pathway as a Target for Pancreatic Cancer Therapy

2016 Pancreatic Cancer Action Network Translational Research Grant
Claudia Gravekamp, PhD, Albert Einstein College of Medicine
Co-PI: Jennifer Chuy, MD, Montefiore Medical Center
Improving Cancer Immunotherapy and Gemcitabine Sensitivity through Listeria

2016 Abby Sobrato – Pancreatic Cancer Action Network Translational Research Grant
Philip Greenberg, MD
Fred Hutchinson Cancer Research Center
Targeting PDA with T-Cells Engineered to Express a Mesothelin-Specific TCR

2014 Samuel Stroum – Pancreatic Cancer Action Network – AACR Fellowship
Barbara Grüner, PhD
Stanford University
Multiplexed In Vivo Drug Screening: Inhibitors of Metastatic Seeding

2007 Pancreatic Cancer Action Network Pilot Grant
Douglas Hanahan, PhD
University of California, San Francisco
Assessing Mechanisms and Therapeutic Potential of an Aspartyle Protease in Pancreatic Cancer

2005 Skip Viragh – Pancreatic Cancer Action Network – AACR Career Development Award
William G. Hawkins, MD
Washington University in St. Louis
Assessing the Ability of Regulatory T-Cell Depletion to Augment Xenogeneic DNA Vaccination Against Mesothelin as a Method to Overcome Immunologic Tolerance in a Murine Model of Pancreas Cancer

2016 Pancreatic Cancer Action Network Translational Research Grant
William Hawkins, MD
Washington University in St. Louis
Targeting Tumor Infiltrating Myeloid Cells to Enhance Immunotherapy

2008 Blum-Kovler – Pancreatic Cancer Action Network – AACR Career Development Award
Joseph Michael Herman, MD
Johns Hopkins University
Evaluation of Focused Radiation to Potentiate a Pancreatic GM-CSF Vaccine

2005 Samuel Stroum – Pancreatic Cancer Action Network – ASCO Young Investigator Award
Aram Hezel, MD
Dana-Farber Cancer Institute
Novel Therapeutic Antibodies for Pancreatic Ductal Adenocarcinoma

grantee-Abel-98x982017 Pancreatic Cancer Action Network Precision Medicine Targeted Grant
Sunil R. Hingorani, MD, PhD
Fred Hutchinson Cancer Research Center
Combining Stromal Disruption and Relief of Immune Suppression to Treat PDA

2004 Samuel Stroum – Pancreatic Cancer Action Network – ASCO Young Investigator Award
David S. Hong, MD
MD Anderson Cancer Center
SRC Kinase Inhibition with BMS-354825 in Pancreatic Cancer Models

grantee-John-Hunter-bw-98x2015 Samuel Stroum – Pancreatic Cancer Action Network – NCI, Frederick National Laboratory for Cancer Research KRAS Fellowship
John Hunter, PhD
UT Southwestern Medical Center
Structural Studies on Mutant K-Ras

2016 Pancreatic Cancer Action Network Translational Research Grant
David Iannitti, MD, Carolinas Medical Center
Co-PI: Rafael Davalos, PhD, Virginia Polytechnic Institute and State University
Developing Next Generation IRE to Treat Pancreatic Cancer

2007 Samuel Stroum – Pancreatic Cancer Action Network -- AACR Young Investigator Award
Hiroyuki Kashiwagi, MD
Washington University in St. Louis
Targeted Delivery of Pro-Apoptotic Therapeutics in Pancreatic Cancer

2014 Fredman Family Foundation – Pancreatic Cancer Action Network – AACR Research Acceleration Network Grant
Dung Le, MD, Johns Hopkins University
Co-Principal Investigator: Todd Crocenzi, MD, Providence Portland Medical Center
GVAX + CRS-207 Heterologous Prime Boost Vaccination with PD-1 Blockade

2015 Pancreatic Cancer Action Network – AACR Research Acceleration Network Grant
Steven Leach, MD, Memorial Sloan-Kettering Cancer Center
Co-PI: Douglas Fearon, MD, Weill Cornell Medical College
Eliminating T cell barriers in pancreatic cancer patients

2016 Pancreatic Cancer Action Network Translational Research Grant
Ann Leen, PhD
Co-PI: William Fisher, MD
Baylor College of Medicine
T-Cell Therapy for Pancreatic Cancer

grantee-Lim-98x982016 Laurie MacCaskill – Pancreatic Cancer Action Network – AACR Career Development Award
Kian-Huat Lim, MD, PhD
Washington University in St. Louis
Deactivating the Innate Immune Defense Mechanism of Pancreatic Cancer

2015 Pancreatic Cancer Action Network Translational Research Grant
David Linehan, MD
University of Rochester
Targeting Inflammatory Monocytes in Metastatic Pancreas Cancer

2016 The Shirley Sadoff – Pancreatic Cancer Action Network Research Acceleration Network-2 Grant
David Linehan, MD, University of Rochester
Co-PI: Brian Wolpin, MD, MPH, Dana-Farber Cancer Institute
Targeting Macrophages to Improve Chemotherapy in Metastatic Pancreas Cancer

2008 Pancreatic Cancer Action Network – AACR Pilot Grant
Bin Liu, PhD
University of California, San Francisco
Internalizing Human Antibodies Targeting Pancreatic Tumor Cells In Situ

2013 Pancreatic Cancer Action Network – AACR Career Development Award
Eric Lutz, PhD
Johns Hopkins University
Exploiting the cancer mutome for personalized tumor immunotherapy

2004 Pancreatic Cancer Action Network – AACR Career Development Award
Anirban Maitra, MD
Johns Hopkins University
Notch Signaling in Pancreas Cancer

2010 Pancreatic Cancer Action Network – AACR Innovative Grant
Frank McCormick, PhD
University of California, San Francisco
Specific K-Ras Inhibitors for Treating Pancreatic Cancer

2015 Pancreatic Cancer Action Network – NCI, Frederick National Laboratory for Cancer Research KRAS Fellowship
Lynn McGregor, PhD
University of California, San Francisco
Development of an Oncogene-Specific Inhibitor of K-Ras G12D

2015 Pancreatic Cancer Action Network Translational Research Grant
Nipun Merchant, MD, University of Miami
Co-PI: Michael VanSaun, PhD
Targeting downstream effectors of KRAS via MEK and CDK-4 inhibition in PDAC

2007 Pancreatic Cancer Action Network Pilot Grant
Pinku Mukherjee, PhD
Mayo Clinic, Scottsdale
Development of Immune-Modulating Therapies Delivered Directly to the Pancreatic Tumor Site

2003 Pancreatic Cancer Action Netwrk – AACR Career Development Award
C. Max Schmidt, MD, PhD
Indiana University
The Chemopreventive Role of Cyclooxygenase Inhibitors in Pancreatic Tumorigenesis

2010 The Randy Pausch Family – Pancreatic Cancer Action Network – AACR Innovative Grant
Diane Simeone, MD
University of Michigan, Ann Arbor
Targeting Notch Signaling in Pancreatic Cancer Stem Cells

2008 Patty Boshell – Pancreatic Cancer Action Network – AACR Career Development Award
Peter Storz, PhD
Mayo Clinic, Jacksonville
Kinases Regulating Pancreatic Cancer Resistance to Chemotherapeutics

grantee-Abel-98x982017 Skip Viragh – Pancreatic Cancer Action Network – AACR Career Development Award
Ingunn Stromnes, PhD
University of Minnesota
Enhancing Efficacy of Engineered T-cell Therapy for Pancreatic Cancer

2010 Pancreatic Cancer Action Network – AACR Innovative Grant
Gloria Su, PhD
Columbia University
Notch Decoy Signaling in Pancreatic Cancer Stem Cells

2012 The Daniel and Janet Mordecai Foundation – Pancreatic Cancer Action Network – AACR Career Development Award
Kazuki Sugahara, MD, PhD
Sanford-Burnham Medical Research Institute
Tissue-Penetrating Drug Delivery to Desmoplastic Pancreatic Tumors

2015 Pancreatic Cancer Action Network Translational Research Grant
Kazuki Sugahara, MD, PhD, Columbia University
Co-PI: Andrew Lowy, MD, FACS, University of California, San Diego
Clinical development of a tumor-penetrating peptide for enhanced pancreatic cancer therapy

grantee-Abel-98x982017 Tap Cancer Out – Pancreatic Cancer Action Network Translational Research Grant
Timothy C. Wang, MD
Co-PI: Paul Oberstein, MD
Columbia University
Targeting Cholinergic Receptors to Suppress Pancreatic Cancer

2007 Seena Magowitz – Pancreatic Cancer Action Network – AACR Career Development Award
Rebekah White, MD
Duke University Medical Center
Prostate Stem Cell Antigen: A Specific Target for Pancreatic Cancer Therapy

2013 Tempur-Pedic – Pancreatic Cancer Action Network – AACR Inaugural Research Acceleration Network Grant in Memory of Tim Miller
Robert Vonderheide, MD, DPhil, University of Pennsylvania
Co-PI: Dafna Bar-Sagi, PhD, New York University
Accelerating Development of CD40 Therapy for Pancreatic Cancer

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.






Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2018 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.